Study Stopped
Staffing unavailability
Patient Recall of Cancer Screening and Diagnosis
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this research is to try to better understand how much information relating to cancer screening and diagnoses that people can recall on their own and to better understand how to help people get better information. In this study, investigators will see if giving time or other resources help individuals remember more and more accurate details about their cancer screening and care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2021
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2021
CompletedFirst Submitted
Initial submission to the registry
August 13, 2021
CompletedFirst Posted
Study publicly available on registry
August 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedFebruary 24, 2026
February 1, 2026
4.4 years
August 13, 2021
February 23, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Completeness of survey
Completeness: For each survey, for each participant, investigators will count the number of "don't know" response rates. From this, investigators will calculate the percent completeness of the survey.
at 1 week (after second survey completed)
Accuracy of survey
Investigators will assess the inter-rater reliability between the first and second survey by calculating a Cohen's Kappa coefficient. Although not a perfect assumption, investigators will use the second survey as the reference. Number of changed answers on an individual level will be calculated, representing improved accuracy. Investigators do not anticipate many changes, and, again, this will not be normally distributed.
at 1 week (after second survey completed)
Study Arms (2)
Control Group
NO INTERVENTIONSurvey questions at baseline and at one week. The control group will have had one week to reflect on the questions, and investigators anticipate some influence of this on responses.
Intervention Group
ACTIVE COMPARATORThe intervention group will be prompted about accessing their medical records from the major local health systems online, with links to directions provided by each hospital system. They will then be asked to fill out the same questionnaire.
Interventions
The participants will receive details on accessing personal medical records online via online portals, for each of the major hospital systems
Eligibility Criteria
You may qualify if:
- diagnosed with breast or prostate cancer within the last 10 years
- have access to the internet with a working email address
- reside in Northeast Ohio
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheryl Thompson, PhD
Case Comprehensive Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 13, 2021
First Posted
August 20, 2021
Study Start
June 22, 2021
Primary Completion
December 1, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
February 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share